A detailed history of American International Group, Inc. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, American International Group, Inc. holds 1,492 shares of SRPT stock, worth $230,066. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,492
Previous 1,513 1.39%
Holding current value
$230,066
Previous $145,000 33.1%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$93.7 - $141.53 $1,967 - $2,972
-21 Reduced 1.39%
1,492 $193,000
Q4 2023

Feb 13, 2024

SELL
$67.31 - $124.76 $2,827 - $5,239
-42 Reduced 2.7%
1,513 $145,000
Q3 2023

Nov 13, 2023

SELL
$102.5 - $123.59 $11,070 - $13,347
-108 Reduced 6.49%
1,555 $188,000
Q2 2023

Aug 04, 2023

BUY
$106.4 - $157.19 $43,730 - $64,605
411 Added 32.83%
1,663 $190,000
Q1 2023

May 12, 2023

SELL
$117.53 - $155.99 $4,348 - $5,771
-37 Reduced 2.87%
1,252 $172,000
Q4 2022

Feb 10, 2023

SELL
$100.86 - $132.13 $2,924 - $3,831
-29 Reduced 2.2%
1,289 $167,000
Q3 2022

Nov 14, 2022

BUY
$75.71 - $119.24 $302 - $476
4 Added 0.3%
1,318 $146,000
Q2 2022

Aug 12, 2022

SELL
$62.69 - $88.44 $16,738 - $23,613
-267 Reduced 16.89%
1,314 $98,000
Q4 2021

Feb 11, 2022

BUY
$77.28 - $99.42 $6,336 - $8,152
82 Added 5.47%
1,581 $142,000
Q3 2021

Nov 12, 2021

SELL
$65.97 - $92.48 $7,520 - $10,542
-114 Reduced 7.07%
1,499 $139,000
Q2 2021

Aug 13, 2021

SELL
$69.38 - $86.75 $5,272 - $6,593
-76 Reduced 4.5%
1,613 $125,000
Q1 2021

May 07, 2021

SELL
$72.25 - $168.95 $14,594 - $34,127
-202 Reduced 10.68%
1,689 $126,000
Q4 2020

Feb 12, 2021

SELL
$125.56 - $178.74 $7,031 - $10,009
-56 Reduced 2.88%
1,891 $322,000
Q3 2020

Nov 04, 2020

SELL
$127.12 - $172.34 $11,313 - $15,338
-89 Reduced 4.37%
1,947 $273,000
Q2 2020

Aug 12, 2020

BUY
$93.0 - $171.7 $40,083 - $74,002
431 Added 26.85%
2,036 $326,000
Q1 2020

May 04, 2020

SELL
$82.38 - $131.64 $4,119 - $6,581
-50 Reduced 3.02%
1,605 $157,000
Q4 2019

Feb 05, 2020

SELL
$76.53 - $135.58 $5,357 - $9,490
-70 Reduced 4.06%
1,655 $214,000
Q2 2019

Aug 13, 2019

BUY
$112.21 - $151.95 $19,636 - $26,591
175 Added 11.29%
1,725 $262,000
Q1 2019

May 06, 2019

SELL
$106.67 - $151.68 $5,866 - $8,342
-55 Reduced 3.43%
1,550 $185,000
Q4 2018

Feb 13, 2019

BUY
$97.32 - $148.76 $10,607 - $16,214
109 Added 7.29%
1,605 $175,000
Q2 2018

Aug 08, 2018

SELL
$71.74 - $153.69 $2.7 Million - $5.77 Million
-37,569 Reduced 96.17%
1,496 $198,000
Q1 2018

May 07, 2018

SELL
$54.02 - $82.27 $113,496 - $172,849
-2,101 Reduced 5.1%
39,065 $2.89 Million
Q4 2017

Feb 09, 2018

BUY
$47.64 - $56.75 $72,508 - $86,373
1,522 Added 3.84%
41,166 $2.29 Million
Q3 2017

Nov 09, 2017

BUY
$35.73 - $47.15 $1.42 Million - $1.87 Million
39,644
39,644 $1.8 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $13.5B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.